JP2023548603A5 - - Google Patents
Info
- Publication number
- JP2023548603A5 JP2023548603A5 JP2023527344A JP2023527344A JP2023548603A5 JP 2023548603 A5 JP2023548603 A5 JP 2023548603A5 JP 2023527344 A JP2023527344 A JP 2023527344A JP 2023527344 A JP2023527344 A JP 2023527344A JP 2023548603 A5 JP2023548603 A5 JP 2023548603A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antibody according
- sequence identity
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063111699P | 2020-11-10 | 2020-11-10 | |
| US63/111,699 | 2020-11-10 | ||
| PCT/US2021/058459 WO2022103700A1 (en) | 2020-11-10 | 2021-11-08 | Antibodies for opioid treatments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023548603A JP2023548603A (ja) | 2023-11-17 |
| JP2023548603A5 true JP2023548603A5 (https=) | 2024-10-17 |
| JP7839789B2 JP7839789B2 (ja) | 2026-04-02 |
Family
ID=81601678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527344A Active JP7839789B2 (ja) | 2020-11-10 | 2021-11-08 | オピオイド治療用抗体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230399418A1 (https=) |
| EP (1) | EP4244256A4 (https=) |
| JP (1) | JP7839789B2 (https=) |
| KR (1) | KR20230107301A (https=) |
| CN (1) | CN116745318A (https=) |
| AU (1) | AU2021377609A1 (https=) |
| CA (1) | CA3200523A1 (https=) |
| IL (1) | IL302673A (https=) |
| MX (1) | MX2023005032A (https=) |
| WO (1) | WO2022103700A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3267132A1 (en) * | 2022-09-09 | 2024-03-14 | Regents Of The University Of Minnesota | ANTIBODIES DIRECTED AGAINST FENTANYL AND ITS ANALOGUES AND THEIR METHODS OF USE |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200808822A (en) * | 2006-04-14 | 2008-02-16 | Amgen Inc | Erythropoietin receptor agonists |
| WO2013095091A2 (en) * | 2011-11-17 | 2013-06-27 | Aimm Therapeutics B.V. | Rsv g protein specific antibodies |
| AU2017345786B2 (en) * | 2016-10-21 | 2024-08-01 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| WO2018140821A1 (en) * | 2017-01-26 | 2018-08-02 | Surrozen, Inc. | Tissue-specific wnt signal enhancing molecules and uses thereof |
| EP3880698A4 (en) * | 2018-11-14 | 2022-11-30 | RubrYc Therapeutics, Inc. | MANIPULATED CD25 POLYPEPTIDES AND USES THEREOF |
-
2021
- 2021-11-08 MX MX2023005032A patent/MX2023005032A/es unknown
- 2021-11-08 WO PCT/US2021/058459 patent/WO2022103700A1/en not_active Ceased
- 2021-11-08 CA CA3200523A patent/CA3200523A1/en active Pending
- 2021-11-08 AU AU2021377609A patent/AU2021377609A1/en active Pending
- 2021-11-08 KR KR1020237019397A patent/KR20230107301A/ko active Pending
- 2021-11-08 CN CN202180085311.0A patent/CN116745318A/zh active Pending
- 2021-11-08 US US18/250,230 patent/US20230399418A1/en active Pending
- 2021-11-08 EP EP21892637.6A patent/EP4244256A4/en active Pending
- 2021-11-08 JP JP2023527344A patent/JP7839789B2/ja active Active
- 2021-11-08 IL IL302673A patent/IL302673A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3484915T3 (fi) | Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä | |
| RU2013102225A (ru) | АНТИТЕЛА ПРОТИВ Axl И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2013538553A5 (https=) | ||
| JP2017501167A5 (https=) | ||
| JP2014527814A5 (https=) | ||
| JP2017530722A5 (https=) | ||
| JP2009541492A5 (https=) | ||
| JP2012525128A5 (https=) | ||
| JP2018508483A5 (https=) | ||
| JP2018529635A5 (https=) | ||
| JP2019511222A5 (https=) | ||
| JP2020514310A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2009511480A5 (https=) | ||
| JP2010528601A5 (https=) | ||
| KR102500868B1 (ko) | 항-cd19 항체 및 bcl-2 억제제의 조합 및 이의 용도 | |
| JP2018535948A5 (https=) | ||
| JP2019527194A5 (https=) | ||
| CA2494008A1 (en) | Anti-myelin associated glycoprotein (mag) antibodies | |
| JP2019511911A5 (https=) | ||
| JP2023515223A5 (https=) | ||
| JP2018529661A5 (https=) | ||
| JP2013508292A5 (https=) | ||
| JP2018512402A5 (https=) | ||
| JP2020533965A5 (https=) |